Cancer Core Europe lecture
Adoptive T cell Therapy for Solid Tumors
Sebastian Klobuch, Medical Oncologist, Center for Cellular Therapy, NKI, Amsterdam
Chimeric antigen receptor (CAR)-T cells have revolutionized the treatment of patients with hematological malignancies. However, so far this success has not been observed in solid tumor patients where response rates were less frequent and mostly not durable.